New hope for Treatment-Resistant schizophrenia? phase 3 trial launches
Symptom relief
Recruiting now
This study tests an experimental drug called evenamide for people with schizophrenia that hasn't improved with standard antipsychotics. About 400 adults will receive either evenamide or a placebo added to their current medication for 12 weeks. The goal is to see if evenamide redu…
Phase: PHASE3 • Sponsor: Newron Pharmaceuticals SPA • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC